Evidence map›Paper›PMID 15240728›Full record

ArticleJournal of immunology (Baltimore, Md. : 1950)2004

Regulation of endotoxin-induced proinflammatory activation in human coronary artery cells: expression of functional membrane-bound CD14 by human coronary artery smooth muscle cells.

Lynn L Stoll, Gerene M Denning, Wei-Gen Li, James B Rice, Allan L Harrelson, Sara A Romig, Skuli T Gunnlaugsson, Francis J Miller, Neal L Weintraub

Open access · bronzeAbstract read
In one paragraph

Article in Journal of immunology (Baltimore, Md. : 1950), 2004. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed, 1 pooled it
2.1field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed, 1 synthesis or guideline pooled it, 95 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Review
  9. Review
  10. Article
  11. Article
  12. Review
  13. Review
  14. Review
  15. Article
  16. Article
  17. Article
  18. Review
  19. Review
  20. The gut microbiome, kidney disease, and targeted interventions.Journal of the American Society of Nephrology : JASN · 2014
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 2 countries.

Lynn L StollDivision of Cardiovascular Diseases, Department of Internal Medicine, University of Iowa, Iowa City, IA 52242, USA. stoll@mail.medicine.uiowa.edu
Gerene M Denning
Wei-Gen Li
James B Rice
Allan L Harrelson
Sara A Romig
Skuli T Gunnlaugsson
Francis J Miller
Neal L Weintraub
University of Iowa · US

Funding

Vascular Protection During HypertensionP01HL062984 · NHLBI · UNIVERSITY OF IOWA · PI SIGMUND, CURT DANIEL · 2000 to 2015
$22.2M
REGULATION OF TG RICH LIPOPROTEIN SECRETION BY OXIDIZED LIPIDSP01HL049264 · NHLBI · UNIVERSITY OF IOWA · PI SPECTOR, ARTHUR A. · 1992 to 2001
$2.6M
Endotoxin, Vascular Inflammation and AtherosclerosisR01HL070860 · NHLBI · UNIVERSITY OF IOWA · PI WEINTRAUB, NEAL L · 2003 to 2006
$1.0M
ENDOTHELIAL DYSFUNCTION OF HUMAN CORONARY ARTERIOLESK08HL003669 · NHLBI · UNIVERSITY OF IOWA · PI MILLER, FRANCIS J · 1997 to 2001
$213k
NHLBI NIH HHS HL-070860NHLBI NIH HHS HL-49264NHLBI NIH HHS HL-62984NHLBI NIH HHS K08 HL003669NHLBI NIH HHS P01 HL062984NHLBI NIH HHS R01 HL070860
6 · The paper itself

Abstract

Low-level endotoxemia has been identified as a powerful risk factor for atherosclerosis. However, little is known about the mechanisms that regulate endotoxin responsiveness in vascular cells. We conducted experiments to compare the relative responses of human coronary artery endothelial cells (HCAEC) and smooth muscle cells (HCASMC) to very low levels of endotoxin, and to elucidate the mechanisms that regulate endotoxin responsiveness in vascular cells. Endotoxin (</=1 ng/ml) caused production of chemotactic cytokines in HCAEC. Endotoxin-induced cytokine production was maximal at LPS-binding protein:soluble CD14 ratios <1, typically observed in individuals with subclinical infection; higher LPS-binding protein:soluble CD14 ratios were inhibitory. Endotoxin potently activated HCASMC, with cytokine release >10-fold higher in magnitude at >10-fold lower threshold concentrations (10-30 pg/ml) compared with HCAEC. This remarkable sensitivity of HCASMC to very low endotoxin concentrations, comparable to that found in circulating monocytes, was not due to differential expression of TLR4, which was detected in HCAEC, HCASMC, and intact coronary arteries. Surprisingly, membrane-bound CD14 was detected in seven different lines of HCASMC, conferring responsiveness to endotoxin and to lipoteichoic acid, a product of Gram-positive bacteria, in these cells. These results suggest that the low levels of endotoxin associated with increased risk for atherosclerosis are sufficient to produce inflammatory responses in coronary artery cells. Because CD14 recognizes a diverse array of inflammatory mediators and functions as a pattern recognition molecule in inflammatory cells, expression of membrane-bound CD14 in HCASMC implies a potentially broader role for these cells in transducing innate immune responses in the vasculature.

Indexed as

ArteriesChemokine CCL2Coronary VesselsEndotoxinsHumansInterleukin-8Lipopolysaccharide ReceptorsMyocytes, Smooth MuscleChemokine CCL2EndotoxinsInterleukin-8Lipopolysaccharide Receptors

Identifiers

PMID15240728
PMCPMC3976648
OpenAlexW1655642906

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.